Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (GZPHF)
OTHER OTC:GZPHF
Total Valuation
Guangzhou Baiyunshan Pharmaceutical Holdings Company has a market cap or net worth of $5.18B. The enterprise value is $43.19B.
Market Cap$5.18B
Enterprise Value$43.19B
Share Statistics
Guangzhou Baiyunshan Pharmaceutical Holdings Company has 219,900,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding219,900,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Guangzhou Baiyunshan Pharmaceutical Holdings Company’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.01%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)4.01%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee2.68M
Profits Per Employee103.27K
Employee Count28,138
Asset Turnover0.89
Inventory Turnover4.87
Valuation Ratios
The current PE Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company is 8.9. Guangzhou Baiyunshan Pharmaceutical Holdings Company’s PEG ratio is 3.10.
PE Ratio8.9
PS Ratio0.34
PB Ratio0.68
Price to Fair Value0.68
Price to FCF-27.11
Price to Operating Cash Flow209.25
PEG Ratio3.10
Income Statement
In the last 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 75.44B and earned 2.91B in profits. Earnings per share was 1.79.
Revenue75.44B
Gross Profit11.45B
Operating Income3.02B
Pretax Income3.59B
Net Income2.91B
EBITDA3.95B
Earnings Per Share (EPS)1.79
Cash Flow
In the last 12 months, operating cash flow was 104.22M and capital expenditures -1.24B, giving a free cash flow of -1.14B billion.
Operating Cash Flow104.22M
Free Cash Flow-1.14B
Free Cash Flow per Share-5.19
Dividends & Yields
Guangzhou Baiyunshan Pharmaceutical Holdings Company pays an annual dividend of $0.056, resulting in a dividend yield of 7.89%
Dividend Per Share$0.056
Dividend Yield7.89%
Payout Ratio26.57%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.13
52-Week Price Change3.82%
50-Day Moving Average2.34
200-Day Moving Average2.30
Relative Strength Index (RSI)65.86
Average Volume (3m)83.00
Important Dates
Guangzhou Baiyunshan Pharmaceutical Holdings Company upcoming earnings date is Apr 28, 2026, TBA (Confirmed).
Last Earnings DateMar 20, 2026
Next Earnings DateApr 28, 2026
Ex-Dividend Date―
Financial Position
Guangzhou Baiyunshan Pharmaceutical Holdings Company as a current ratio of 1.57, with Debt / Equity ratio of 54.75%
Current Ratio1.57
Quick Ratio1.24
Debt to Market Cap0.79
Net Debt to EBITDA1.46
Interest Coverage Ratio7.26
Taxes
In the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Company has paid 612.93M in taxes.
Income Tax612.93M
Effective Tax Rate0.17
Enterprise Valuation
Guangzhou Baiyunshan Pharmaceutical Holdings Company EV to EBITDA ratio is 8.00, with an EV/FCF ratio of -33.14.
EV to Sales0.42
EV to EBITDA8.00
EV to Free Cash Flow-33.14
EV to Operating Cash Flow124.77
Balance Sheet
Guangzhou Baiyunshan Pharmaceutical Holdings Company has $23.81B in cash and marketable securities with $20.70B in debt, giving a net cash position of $3.12B billion.
Cash & Marketable Securities$23.81B
Total Debt$20.70B
Net Cash$3.12B
Net Cash Per Share$14.17
Tangible Book Value Per Share$22.83
Margins
Gross margin is 16.02%, with operating margin of 4.01%, and net profit margin of 3.85%.
Gross Margin16.02%
Operating Margin4.01%
Pretax Margin4.76%
Net Profit Margin3.85%
EBITDA Margin5.24%
EBIT Margin4.01%
Analyst Forecast
The average price target for Guangzhou Baiyunshan Pharmaceutical Holdings Company is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―